Lamictal XR Gains Indication for Conversion to Monotherapy for Partial Seizures - MPR
Links shared publicly online about this topic.
- 337total visits
Lamictal XR Gains Indication for Conversion to Monotherapy for Partial Seizures - MPR
empr.com —
View full resource at empr.com
Tags: Seizure, Seizure Medication, Drug, FDA, Lamictal, GlaxoSmithKline, Epilepsy Medication, News
Most Recently Shared on April 26, 2011 at 2:49 pm By:
MPR News: Lamictal XR Gains Indication for Conversion to Monotherapy for Partial Seizures: GlaxoSmithKline annou... http://bit.ly/f1O3UB
Lamictal XR Gains Indication for Conversion to Monotherapy for Partial Seizures - ONA
oncologynurseadvisor.com — “GlaxoSmithKline announced that the FDA has approved Lamictal XR (lamotrigine extended-release tablets) for conversion to monotherapy in patients 13 years with partial seizures taking one anti-epileptic drug.” View full resource at oncologynurseadvisor.com
Most Recently Shared on April 26, 2011 at 2:45 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Lamictal XR Gains Indication for Conversion to Monotherapy for Partial Seizures http://goo.gl/fb/3ppjU
Advertisement
